| Patients admitted with COVID-19 infection with chronic disease (38.34%) (Group A) | Patients admitted with COVID-19 infection without chronic disease (74.66%) (Group B) | p-Value |
Average age at diagnosis | 7.7 ± 5.6 | 10.5 ± 5.9 | 0.017 |
Gender (M %) | 53% | 45% | 0.423 |
Symptomatic (n, %) |
|
|
|
- Cough | 15 (39.5) | 17 (23.0) | 0.070 |
- Fever | 15 (39.5) | 14 (18.9) | 0.020 |
- Fatigue | 10 (26.3) | 8 (10.8) | 0.037 |
- Nasal symptoms | 5 (13.2) | 12 (16.2) | 0.676 |
- Dyspnea | 9 (23.7) | 6 (8.1) | 0.024 |
- Headache | 2 (5.3) | 11 (14.9) | 0.758 |
- Sore throat | 1 (2.6) | 11 (14.9) | 0.049 |
- Vomiting | 1 (2.6) | 8 (10.8) | 0.133 |
- Others (tachycardia, chest pain, unsteady gait) | 3 (7.9) | 5 (6.8) | 0.831 |
- Muscle aches | 5 (13.2) | 3 (4.1) | 0.080 |
- Tachypnea | 3 (7.9) | 4 (5.4) | 0.606 |
- Abdominal pain | 2 (5.3) | 5 (6.8) | 0.758 |
- Diarrhea | 0 | 5 (6.8) | 0.103 |
- Poor appetite | 3 (7.9) | 1 (1.3) | 0.076 |
- Hypoactivity | 2 (5.3) | 0 | 0.048 |
- Loss of smell | 0 | 0 |
|
- Loss of taste | 0 | 0 |
|
Radiological evaluation: |
|
|
|
- Abnormal CXR (n, %) | 14 (36.8) | 13 (17.6) | 0.027 |
Laboratory evaluation: |
|
|
|
- High inflammatory markers (ESR, CRP) | 5 (13.2) | 12 (16.2) | 0.676 |
- Average LDH | 560 | 417 |
|
- Average Ferritin | 100 | 32.1 |
|
- Hb (Avg ± SD) | 12.2 ± 1.80 | 12.6 ± 1.67 | 0.353 |
- WBC | 8634.6 ± 5947.04 | 7622 ± 2972 | 0.327 |
- Lymphocyte count | 3039.69 ± 3410.97 | 2447.84 ± 1234.4 | 0.286 |
- Neutrophilic count | 4284.49 ± 3025.9 | 3820.3 ± 2138.27 | 0.454 |
- Platelet count | 270,807 ± 202832.5 | 279145.8 ± 149500.4 | 0.844 |
Level of care: |
|
|
|
- Floor | 33 (86.8) | 71 (95.9) | 0.080 |
- ICU | 5 (13.2) | 3 (4.1) | 0.080 |
Highest respiratory support: |
|
|
|
- None | 32 (84.2) | 73 (98.6) | 0.036 |
- CPAP | 2 (5.3) | 0 | 0.048 |
- HFNC | 1 (2.6) | 1 (1.4) | 0.652 |
- Mechanical ventilation | 3 (7.9) | 0 | 0.016 |
COVID-19 specific treatment: |
|
|
|
- Hydroxychloroquine | 1 (2.6) | 8 (10.8) | 0.133 |
- Steroids | 5 (13.2) | 3 (4.1) | 0.080 |
- IVIG | 1 (2.6) | 1 (1.4) | 0.653 |
- Remdesivir | 0 | 1 (1.4) | 0.465 |
- Azithromycin | 1 (2.6) | 0 | 0.166 |
Outcome: |
|
|
|
- Death | 5 (13.2) | 0 | 0.002 |